Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Chemists at the University of Bath have cracked the code on making fluorescent probes brighter and more versatile, using a naturally occurring blue molecule called azulene. By tweaking its molecular structure, they created probes up to five times brighter than the original — a potential game-changer for imaging diseases like Alzheimer's, Parkinson's, and cancer at the cellular level.
Chemists at the University of Bath have developed a blueprint for designing next-generation fluorescent probes using azulene — a naturally occurring blue compound found in certain mushrooms and corals. Published in Organic Chemistry Frontiers, the study reveals how small tweaks to azulene's molecular structure can dramatically change the color and brightness of fluorescent signals, offering a roadmap for building more powerful imaging tools.
Fluorescent probes work by binding to specific molecules inside cells and lighting up under a microscope, making invisible biological processes visible. The team's AzuFluor® platform creates a family of azulene-based probes designed to monitor molecular events in real time — with applications spanning Alzheimer's disease, Parkinson's disease, cancer, and asthma research.
By the Numbers
Why it matters: Brighter, more precise fluorescent probes mean researchers can detect subtle cellular changes earlier and more accurately — potentially accelerating diagnosis and drug development for some of the world's most challenging diseases.